Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Epilepsy D004827 35 associated lipids
Seizures D012640 87 associated lipids
Nerve Degeneration D009410 53 associated lipids
Birth Weight D001724 23 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Nasal Polyps D009298 26 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Ear Diseases D004427 7 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Agranulocytosis D000380 7 associated lipids
Shock D012769 11 associated lipids
Polycythemia Vera D011087 13 associated lipids
Hyperalgesia D006930 42 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Ventricular Fibrillation D014693 16 associated lipids
Fever D005334 35 associated lipids
Anaphylaxis D000707 35 associated lipids
Pneumococcal Infections D011008 7 associated lipids
Thrombocytopenia D013921 15 associated lipids
Bronchial Spasm D001986 18 associated lipids
Shock, Septic D012772 11 associated lipids
Immune Complex Diseases D007105 9 associated lipids
Conjunctivitis D003231 7 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Rheumatic Diseases D012216 7 associated lipids
Death, Sudden D003645 12 associated lipids
Vitamin E Deficiency D014811 29 associated lipids
Cardiomegaly D006332 31 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Carbon Monoxide Poisoning D002249 9 associated lipids
Neutropenia D009503 15 associated lipids
Extravasation of Diagnostic and Therapeutic Materials D005119 3 associated lipids
Meningioma D008579 11 associated lipids
Multiple Trauma D009104 2 associated lipids
Cluster Headache D003027 4 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Glomerulonephritis, IGA D005922 7 associated lipids
Behcet Syndrome D001528 7 associated lipids
Escherichia coli Infections D004927 17 associated lipids
Migraine Disorders D008881 11 associated lipids
Malabsorption Syndromes D008286 16 associated lipids
Pregnancy Complications, Cardiovascular D011249 11 associated lipids
Thrombasthenia D013915 4 associated lipids
Gastrointestinal Hemorrhage D006471 27 associated lipids
Disseminated Intravascular Coagulation D004211 7 associated lipids
Shock, Traumatic D012774 4 associated lipids
Hemorrhagic Fever, American D006478 2 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Arthus Reaction D001183 8 associated lipids
Thrombocytosis D013922 4 associated lipids
Toxemia D014115 3 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Duodenal Ulcer D004381 12 associated lipids
Angina Pectoris D000787 27 associated lipids
Angina, Unstable D000789 14 associated lipids
Pregnancy Complications, Hematologic D011250 11 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Klebsiella Infections D007710 7 associated lipids
Ascites D001201 25 associated lipids
Albuminuria D000419 18 associated lipids
Infant, Premature, Diseases D007235 7 associated lipids
Hyperinsulinism D006946 27 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Parkinson Disease D010300 53 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Salmonella Infections, Animal D012481 9 associated lipids
Bronchial Diseases D001982 3 associated lipids
Central Nervous System Diseases D002493 10 associated lipids
Tangier Disease D013631 8 associated lipids
Heart Arrest D006323 13 associated lipids
Cystitis D003556 23 associated lipids
Cholecystitis D002764 8 associated lipids
HIV Infections D015658 20 associated lipids
Subacute Sclerosing Panencephalitis D013344 3 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
AIDS Dementia Complex D015526 4 associated lipids
Constriction, Pathologic D003251 8 associated lipids
Medulloblastoma D008527 22 associated lipids
Zellweger Syndrome D015211 39 associated lipids
Coronary Thrombosis D003328 7 associated lipids
Glomerulonephritis, Membranous D015433 6 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Hypertension, Portal D006975 12 associated lipids
Atherosclerosis D050197 85 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Dyslexia D004410 3 associated lipids
Leukemia, Eosinophilic, Acute D015472 3 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Madi S et al. Allergen-induced bronchospasm in passively sensitized guinea pigs: influence of new substances in comparison to reference compounds. 1991 Agents Actions pmid:2058463
Braquet P and Esanu A New trends in PAF antagonist research: a new series of potent hetrapazine-derived PAF antagonists. 1991 Agents Actions pmid:2058466
Will PC et al. Platelet activating factor as a proinflammatory mediator in acetic-induced colitis in the rat. 1991 Agents Actions pmid:1793026
McLeod J et al. Effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on substance P-induced histamine release from rat peritoneal mast cells. 1990 Agents Actions pmid:1695435
Adolfs MJ et al. PAF-acether modifies human peritoneal macrophage cAMP levels in a biphasic fashion. 1989 Agents Actions pmid:2540635
Neumann M and Kownatzki E The effect of adherence on the generation of reactive oxygen species by human neutrophilic granulocytes. 1989 Agents Actions pmid:2540640
Bekemeier H and Sänze JU Vasodepression ex vivo after administration of inflammatory mediators in vivo in the rat. 1989 Agents Actions pmid:2476918
Jouquey S et al. Comparison of the effects of the ace inhibitors trandolapril and enalapril on phlogogen induced foot pad oedema in the rat. 1988 Agents Actions pmid:2459935
Zijlstra FJ et al. The effects of PAF-acether and FMLP on eicosanoid production in guinea pig alveolar macrophages. 1989 Agents Actions pmid:2711928
Nijkamp FP et al. Role of platelet activating factor in the endotoxin induced tracheal hyperreactivity to histamine in the guinea pig. 1989 Agents Actions pmid:2711929
Oliver JL et al. Effect of PAF acether on oriented egg phosphatidylcholine multibilayers; interaction with cholesterol; comparison to lyso-PC and lyso-PAF. 1989 Agents Actions pmid:2711930
Jenei B et al. Hypotensive action of IgG preparations containing aggregates is suppressed by PAF-receptor antagonist BN 52021 and by gadolinium chloride (an agent blocking Kupffer cell function). 1991 Agents Actions pmid:1862750
Kantar A et al. Effect of PAF on erythrocyte membrane heterogeneity: a fluorescence study. 1991 Agents Actions pmid:1862752
Anderson GP et al. Increased airways responsiveness to histamine induced by platelet activating factor in the guinea-pig: possible role of lipoxygenase metabolites. 1988 Agents Actions pmid:3136622
Ramesha CS et al. Identification and quantitation of PAF from psoriatic scales. 1987 Agents Actions pmid:3687590
Friedlander G et al. Renal effects of platelet-activating factor in the rat. 1987 Agents Actions pmid:3687594
Taira M et al. Lack of involvement of leukotriene and platelet activating factor in passive cutaneous anaphylaxis in rats. 1988 Agents Actions pmid:3407549
Kusner EJ et al. Pharmacologic analysis of 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced increases in cutaneous vascular permeability in the rat. 1987 Agents Actions pmid:3577957
Pirotzky E et al. Vascular permeability induced by Paf-acether (platelet-activating factor) in the isolated perfused rat kidney. 1985 Agents Actions pmid:4003192
Northover AM In vitro effects of PAF on venous endothelial cell actin disposition. 1992 Agents Actions pmid:1509977
Benveniste J Platelet-activating factor (PAF-acether): present status. 1981 Agents Actions pmid:6176101
Northover AM and Northover BJ Lectin-induced increase in microvascular permeability to colloidal carbon in vitro may involve protein kinase C activation. 1994 Agents Actions pmid:7942320
Tubaro E et al. In vitro and in vivo impact of a new glycosphingolipid on neutrophils. 1994 Agents Actions pmid:7879694
Perret BA et al. Binding of bovine factor VIII-coated colloidal gold particles to receptors on platelet membranes. 1981 Agents Actions pmid:6803540
Lecrubier C et al. Study of platelet aggregation induced by platelet activating factor (PAF) after administration of ticlopidine or aspirin. 1983 Agents Actions pmid:6858789
Vargaftig BB Platelet-activating factor (PAF-acether) 1982 Agents Actions pmid:7164939
Vargaftig BB et al. Platelet-tissue interaction: role of platelet-activating factor (PAF-acether). 1980 Agents Actions pmid:7270336
Sullivan MH et al. Altered platelet responses to P.A.F. in pregnancy-induced hypertension. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825415
Braquet P et al. From ginkgolides to N-substituted piperidino-thieno diazepines, a new series of highly potent dual antagonists. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825436
Berti F et al. Opposite effects of PGI2 and PAF generated during acute myocardial ischemia in the perfused rabbit heart. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825437
Takatani M et al. Platelet activating factor (PAF) antagonists: development of a highly potent PAF antagonist, TCV-309. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825438
Kawabe T et al. Role of PAF and cytokines in the modulation of Fc epsilon RII/CD23 expression on human eosinophils. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825444
Weber PC and Sellmayer A Modification of the eicosanoid system and cell signalling by precursor fatty acids. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825543
Balazy M et al. A novel method for the analysis of PAF and alkyl-ether phospholipids by mass spectrometry. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825562
Magni F et al. Determination of platelet-activating factor in biological samples by high resolution mass spectrometry. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825563
Coceani F et al. Leukotrienes in cerebrospinal fluid of the conscious cat: effect of platelet-activating factor and pyrogens. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825586
Shen TY et al. Recent development of platelet-activating factor antagonists. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2546389
Handley DA et al. Chemistry and pharmacology of PAF antagonists. Evaluation of changes at potential metabolism sites on activity and duration of activity. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2546390
Dray F et al. Recent studies on icosanoids and PAF-acether modulation of some central neurosecretions in the rat. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2546391
Desquand S et al. Interference of the PAF-acether antagonist BN 52021 with anaphylaxis in the guinea pig. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2445183
Benveniste J PAF-acether (platelet-activating factor). 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526498
Hsueh W and Sun XM Tumor necrosis factor-induced bowel necrosis: the role of platelet-activating factor. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526499
Pignol B et al. Effect of chronic administration of platelet-activating factor (PAF) in the guinea-pig and the rat. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526500
Foegh ML et al. Platelet-activating factor in organ transplant rejection. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526501
Pickett WC and Ramesha C Modulation of mediator precursors by changes in essential fatty acid composition. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526546
Bussolino F et al. Chick retina generates platelet-activating factor. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2890284
Braquet P Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L. 1986 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2949548
Foegh ML et al. Leukotrienes, thromboxane, and platelet activating factor in organ transplantation. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2959038
Robertson DN and Smith GM Role of thromboxane A2, 5-hydroxytryptamine, and platelet activating factor in collagen-induced sudden death in rabbits. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2959049
d'Humieres S et al. Platelet activating factor acether is involved in thrombin-induced synthesis of prostacyclin by human endothelial cells. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2959051
Whittle BJ et al. Gastric vascular and mucosal damaging actions of platelet activating factor in the canine stomach. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2959063
Montrucchio G et al. In vitro oxytocic activity of platelet-activating factor on human myometrium. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960158
Mallet AI et al. Platelet activating factor in chronic plaque psoriasis. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960170
Bourgain RH et al. Effect of ginkgolide PAF-acether antagonists on arterial thrombosis. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960196
Braquet P et al. Platelet-activating factor: a potential mediator of shock. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960197
Myers A et al. Pharmacological manipulation of platelet-activating factor toxicity in rodents. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960198
Benveniste J Biosynthesis and function of PAF-acether (platelet-activating factor). 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936197
Waku K et al. Metabolism of 1-O-alkyl-2-acyl-sn-glycero-3-phosphocholine: a precursor of platelet-activating factor in macrophages. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936199
Saito K et al. Determination of AGEPC generated from human neutrophils and rat skin and muscle tissues by a selected ion monitoring technique of GC/MS. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936200
Hanahan DJ et al. Platelet-activating factor: a unique lipid chemical mediator. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936201
Inoue K et al. Activation of guinea pig peritoneal macrophages by platelet-activating factor in free form or incorporated into liposomes. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936203
Benveniste J Paf-acether (platelet-activating factor). 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:3159192
Matsumoto M and Miwa M Platelet-activating factor-binding protein in human serum. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:3004155
Terashita Z et al. Beneficial effects of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate, a specific PAF antagonist, in endotoxin and anaphylactic shock. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:3004156
Livio M et al. A platelet-activating factor receptor antagonist protects against renal function deterioration in nephrotoxic nephritis. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2823570
Vargaftig BB et al. Synergized activation of human platelets by epinephrine and platelet-activating factor-acether is adenosine diphosphate and thromboxane A2-independent. 1983 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:6221558
Voelkel NF et al. Platelet-activating factor causes pulmonary vasoconstriction and edema via platelet-independent leukotriene formation. 1983 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:6221590
Izumi T et al. Regulation and signal transduction of PAF receptor. 1995 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:7732892
Bennett SA and Birnboim HC Platelet activating factor induces transformation of human fibroblasts. 1995 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:7732893
Summers JB et al. ABT-299, a potent antagonist of platelet activating factor. 1995 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:7732895
Koltai M et al. Platelet-activating factor antagonists: scientific background and possible clinical applications. 1994 Adv. Pharmacol. pmid:8080821
Summers JB and Albert DH Platelet activating factor antagonists. 1995 Adv. Pharmacol. pmid:7748804
Pirotzky E et al. Involvement of platelet-activating factor in renal processes. 1989 Adv. Lipid Res. pmid:2698054
Holleran WM Lipid modulators of epidermal proliferation and differentiation. 1991 Adv. Lipid Res. pmid:1763711
Paubert-Braquet M et al. Platelet-activating factor amplifies tumour necrosis factor-induced superoxide generation by human neutrophils. 1990 Adv. Exp. Med. Biol. pmid:2173875
Vernadakis A et al. C-6 glioma cells of early passage have progenitor properties in culture. 1991 Adv. Exp. Med. Biol. pmid:1685850
Schlondorff D Interactions of platelet activating factor and prostaglandins in the glomerulus and in mesangial cells. 1989 Adv. Exp. Med. Biol. pmid:2696352
Remuzzi G Eicosanoids and platelet activating factor as possible mediators of injury in experimental nephropathies. 1989 Adv. Exp. Med. Biol. pmid:2696353
Rabinovici R et al. PAF and TNF alpha interactions in the pathophysiology of septic shock. 1991 Adv. Exp. Med. Biol. pmid:1818486
Jin N et al. Platelet activating factor causes relaxation of isolated pulmonary artery and aorta. 1991 Adv. Exp. Med. Biol. pmid:1803920
Bourgain RH et al. Arterial obstruction induced by PAF-acether (1-O-alkyl-sn-glycero-3-phosphocholine). 1987 Adv. Exp. Med. Biol. pmid:3673721
Fisher RA et al. AGEPC: a potent calcium-dependent chemical mediator in the liver. 1988 Adv. Exp. Med. Biol. pmid:3213685
van Rossem K et al. The role of PAF and the effect of a specific PAF antagonist on local tissue PO2 and neuronal integrity during and after photothrombotic brain infarction in unanesthetised rabbits. 1996 Adv. Exp. Med. Biol. pmid:8798843
Shimizu T and Mutoh H Structure and regulation of platelet activating factor receptor gene. 1997 Adv. Exp. Med. Biol. pmid:9321953
Mori M et al. Localization of platelet-activating factor receptor in the rat brain. 1997 Adv. Exp. Med. Biol. pmid:9321976
Erickson KL et al. Alteration of platelet activating factor-induced macrophage tumoricidal response, IA expression, and signal transduction by N-3 fatty acids. 1997 Adv. Exp. Med. Biol. pmid:9321978
Muguruma K et al. The central role of PAF in necrotizing enterocolitis development. 1997 Adv. Exp. Med. Biol. pmid:9321979
Aoki Y et al. A simple, rapid and specific radioreceptor assay for platelet-activating factor. 1997 Adv. Exp. Med. Biol. pmid:9321990
Ye RD et al. Stimulation of NF-kappa B activation and gene expression by platelet-activating factor. 1996 Adv. Exp. Med. Biol. pmid:9131140
Shukla SD Tyrosine kinase activation by PAF leads to downstream gene expression. 1996 Adv. Exp. Med. Biol. pmid:9131141
Morooka S and Natsume Y Effect of SM-12502 on disseminated intravascular coagulation (DIC) in tumor-bearing rats. 1996 Adv. Exp. Med. Biol. pmid:9131147
Sanchez Crespo M et al. Platelet-activating factor is an effector of rapid reactions and an inductor of late responses in immune-mediated injury. 1996 Adv. Exp. Med. Biol. pmid:9131148
Saito K PAF response to inflammatory and non-inflammatory stimuli. 1996 Adv. Exp. Med. Biol. pmid:9131150
Silver D et al. Role of platelet-activating factor in skeletal muscle ischemia-reperfusion injury. 1996 Adv. Exp. Med. Biol. pmid:9131151
Lopes-Martins RA et al. Platelet-activating factor. A possible role in the modulation of the vasomotor tone and blood pressure. 1996 Adv. Exp. Med. Biol. pmid:9131152
Camussi G et al. Platelet-activating factor and angiogenesis. 1996 Adv. Exp. Med. Biol. pmid:9131153
Oh-Ishi S et al. Role of synergistic action of PAF and kinin in bacterial endotoxin-induced hypotension in rats. 1996 Adv. Exp. Med. Biol. pmid:9131154
Tetta C et al. The role of platelet-activating factor in the biocompatibility of hemodialysis membranes. 1996 Adv. Exp. Med. Biol. pmid:9131156
Ohkuni H et al. Purification and partial characterization of a novel human platelet aggregation factor in the extracellular products of Streptococcus mitis, strain Nm-65. 1997 Adv. Exp. Med. Biol. pmid:9331745
Kosar-Hashemi B et al. Glyceryl ether monooxygenase [EC 1.14.16.5]: stoichiometry and inhibition. 1993 Adv. Exp. Med. Biol. pmid:8304231